133 related articles for article (PubMed ID: 27416700)
1. [Targeted therapy for renal cell carcinoma].
Terai K; Horie S
Nihon Jinzo Gakkai Shi; 2016; 58(4):568-72. PubMed ID: 27416700
[No Abstract] [Full Text] [Related]
2. Targeted therapy: An elusive cancer target.
Brown C
Nature; 2016 Sep; 537(7620):S106-8. PubMed ID: 27626779
[No Abstract] [Full Text] [Related]
3. [Renal cell carcinoma: the end of a tunnel?].
Ravaud A; Dilhuydy MS
Pathol Biol (Paris); 2006 May; 54(4):206-8. PubMed ID: 16530346
[No Abstract] [Full Text] [Related]
4. Perspective: What next for treatment?
Motzer RJ
Nature; 2016 Sep; 537(7620):S111. PubMed ID: 27626781
[No Abstract] [Full Text] [Related]
5. [Development of angiogenesis inhibitory combination therapies for treatment of renal cell carcinoma].
Bartsch G; Eggert K; Soker S; Fiedler W; Laack E; Volkmer BG; Gschwend J; Bokemeyer C; Hautmann R; Schuch G
Urologe A; 2007 Sep; 46(9):1289-90. PubMed ID: 17624513
[No Abstract] [Full Text] [Related]
6. Interleukin-2 continuous infusion and angiogenesis surrogate markers in metastatic renal cell carcinoma.
Simonelli C; Talamini R; Bearz A; Berretta M; Spazzapan S; Monini P; Sgadari C; Sartor I; Ensoli B; Tirelli U
Ann Oncol; 2006 Aug; 17(8):1335-6. PubMed ID: 16569648
[No Abstract] [Full Text] [Related]
7. [The pathologist's role in the neoadjuvant strategy of renal-cell carcinoma].
Leroy X; Edeline J; Rioux-Leclercq N
Ann Pathol; 2011 Dec; 31(6):466-71. PubMed ID: 22172119
[TBL] [Abstract][Full Text] [Related]
8. Interview with professor Per-Anders Abrahamson: angiogenesis and renal cell carcinoma.
Abrahamson PA
Eur Urol; 2006 Sep; 50(3):609-11. PubMed ID: 16824676
[No Abstract] [Full Text] [Related]
9. What's new in renal cell carcinoma.
Meng MV; Nelson H
Bull Am Coll Surg; 2012 Aug; 97(8):65-6. PubMed ID: 22973751
[No Abstract] [Full Text] [Related]
10. Predictive biomarkers in renal cell cancer: insights in drug resistance mechanisms.
van der Mijn JC; Mier JW; Broxterman HJ; Verheul HM
Drug Resist Updat; 2014; 17(4-6):77-88. PubMed ID: 25457974
[TBL] [Abstract][Full Text] [Related]
11. [Invasion, metastasis and angiogenesis of renal cell carcinoma].
Tsukamoto T
Nihon Hinyokika Gakkai Zasshi; 1996 Jan; 87(1):1-12. PubMed ID: 8683887
[No Abstract] [Full Text] [Related]
12. Effects of antiangiogenic therapy.
von Falck C; Wacker F; Rosenthal H
J Vasc Interv Radiol; 2012 Nov; 23(11):1503. PubMed ID: 23101922
[No Abstract] [Full Text] [Related]
13. Targeting fibroblast growth factor receptor (FGFR) pathway in renal cell carcinoma.
Massari F; Ciccarese C; Santoni M; Lopez-Beltran A; Scarpelli M; Montironi R; Cheng L
Expert Rev Anticancer Ther; 2015; 15(12):1367-9. PubMed ID: 26568023
[TBL] [Abstract][Full Text] [Related]
14. The value of cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy.
You D; Jeong IG; Ahn JH; Lee DH; Lee JL; Hong JH; Ahn H; Kim CS
J Urol; 2011 Jan; 185(1):54-9. PubMed ID: 21074811
[TBL] [Abstract][Full Text] [Related]
15. Relationships between the effect of sunitinib and immature blood vessels in metastatic renal cell cancer.
Kim BH; Sohn JC; Ha JY; Park CH; Choe MS; Jung HR; Kim CI
Urol Int; 2015; 94(2):137-43. PubMed ID: 25138147
[TBL] [Abstract][Full Text] [Related]
16. Emerging therapeutic approaches in renal cell carcinoma.
Parekh H; Rini BI
Expert Rev Anticancer Ther; 2015; 15(11):1305-14. PubMed ID: 26376584
[TBL] [Abstract][Full Text] [Related]
17. [The role of angiogenesis in renal carcinoma].
Bussolati B; Satolli MA; Camussi G
G Ital Nefrol; 2008; 25(3):297-305. PubMed ID: 18473301
[TBL] [Abstract][Full Text] [Related]
18. Cytoreductive nephrectomy for metastatic renal cell carcinoma.
McKiernan J; Wood CG
J Urol; 2013 Aug; 190(2):386-8. PubMed ID: 23702308
[No Abstract] [Full Text] [Related]
19. Is tumor response important for renal carcinoma?
Inman BA; George DJ
Eur Urol; 2011 Jan; 59(1):16-7. PubMed ID: 20970245
[No Abstract] [Full Text] [Related]
20. What do we need to make genetic biomarker-guided treatment for renal cell carcinoma a reality?
Diekstra MH; Liu X; Swen JJ; Guchelaar HJ
Pharmacogenomics; 2017 Jan; 18(1):1-4. PubMed ID: 27967336
[No Abstract] [Full Text] [Related]
[Next] [New Search]